Tech Company Inital Public Offerings
Passage Bio IPO
Headquartered in Philadelphia, Passage Bio is now a public company.
Transaction Overview
Company Name
Announced On
2/28/2020
Transaction Type
IPO
Amount
$216,000,000
Proceeds Purpose
Use of proceeds for the Passage Bio IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2 Commerce Sq.
Philadelphia, PA 19103
USA
Philadelphia, PA 19103
USA
Phone
Website
Email Address
Not Recorded
Overview
Passage Bio was recently launched with the vision to be a first in class fully-integrated biotech company developing life transforming AAV-delivered in vivo therapeutics for the treatment of rare CNS diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Squinto
Chief Operating Officer
Jill Quigley
Browse more venture capital transactions:
Prev: 2/28/2020: SWORD Health venture capital transaction
Next: 2/28/2020: Gridwise venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs